Trending
- Unjustifiable to trap Prof Ashok Pandey, the top biotechnologist from India in the game of publishing conduct
- Covishield was dangerous and Covaxin was like placebo, they all fooled us for their own benefits: Vaccine Expert Prof Guntaka Ramareddy, India’s first recombinant vaccine developer
- The 48th Annual meeting and international conference of the Indian Society of Human Genetics
- Dr. Krishna Ella Awarded the Johns Hopkins Bloomberg School Highest Medal of Honour for Exceptional Work in Public Health
- Antibiotics Market Size to Reach USD 85.80 Billion by 2033
- Biocon Biologics Enters U.S. Ophthalmology Market after Obtaining U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™
- A trial HIV vaccine triggered elusive and essential antibodies in humans
- Chinese virologist who was first to share COVID-19 genome sleeps on street after lab